Building a CTMS, EDC, eCOA, ePRO, eConsent, or any clinical-trial platform? GreatCTO auto-attaches clinical-trials-pack (paired with bio-data) for ICH-GCP E6(R3), 21 CFR Part 11 audit trail + e-signatures, CDISC SDTM/ADaM, FHIR R5/HL7/OMOP/DICOM conformance, de-identification (Safe Harbor or Expert Determination ≤ 0.04), and AE/SAE 24h reporting.
clinical trial · CTMS · EDC · eCOA · ePRO · eConsent · IRB · CDISC · FHIR · HL7 · DICOM · OMOP · genomics
The pack rides on top of your base archetype (web-service, ai-system, fintech, …) — it doesn't replace it. Auto-injects reviewer agents into the pipeline + opens human gates listed below.
ICH-GCP E6(R3) + 21 CFR Part 11 + CDISC + IRB + AE/SAE + DCT
FHIR R5 + HL7 + OMOP + DICOM + VCF/BAM/CRAM + Safe Harbor de-id + GA4GH DUO
gate:plan + gate:ship.| Gate | Owner | Trigger |
|---|---|---|
gate:irb-ready | clinical lead + regulatory | before IRB submission |
gate:part11-validation | independent QA lead | before production go-live |
gate:deidentification | statistical expert | if Expert Determination used |
Each EVAL has ≥5 test cases, pass threshold, regression interpretation, cross-refs to TM + gates. Run via your existing test framework.
EVAL-trial-audit-trail-immutability.mdEVAL-trial-consent-versioning.mdEVAL-trial-ae-reporting-latency.mdEVAL-trial-cdisc-export-conformance.mdEVAL-biodata-deid-reidentification-risk.mdEVAL-biodata-dicom-phi-burn.mdListed companies operate in this space. Inclusion is based on publicly available product descriptions and does not imply endorsement of or by GreatCTO.
packs: in PROJECT.md./migrate to re-run detection with updated rules.$ npx great-cto init